The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 20389 | Last update: 13.09.2023
REACH Authorisation Decisions List of authorisation decisions adopted on the basis of Article 64 of Regula...
Regolamento (UE) N. 125/2012 della Commissione del 14 febbraio 2012 recante modifica dell’allegato XIV del regolamento (CE) n. 1907/2006 del Parlamento europeo e del Consig...
ID 26495 | 20 Giugno 2026 / Allegata Proposta di Regolamento
Il 17 giugno 2026, il Consiglio e il Parlamento europeo ha...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
